Logo image
Effect of atelectasis changes on tissue mass and dose during lung radiotherapy
Journal article   Open access   Peer reviewed

Effect of atelectasis changes on tissue mass and dose during lung radiotherapy

Christopher L Guy, Elisabeth Weiss, Nuzhat Jan, Leonid B Reshko, Gary E Christensen and Geoffrey D Hugo
Medical physics (Lancaster), Vol.43(11), pp.6109-6117
11/2016
DOI: 10.1118/1.4965807
PMCID: PMC5085974
PMID: 27806593
url
https://doi.org/10.1118/1.4965807View
Published (Version of record) Open Access

Abstract

To characterize mass and density changes of lung parenchyma in non-small cell lung cancer (NSCLC) patients following midtreatment resolution of atelectasis and to quantify the impact this large geometric change has on normal tissue dose. Baseline and midtreatment CT images and contours were obtained for 18 NSCLC patients with atelectasis. Patients were classified based on atelectasis volume reduction between the two scans as having either full, partial, or no resolution. Relative mass and density changes from baseline to midtreatment were calculated based on voxel intensity and volume for each lung lobe. Patients also had clinical treatment plans available which were used to assess changes in normal tissue dose constraints from baseline to midtreatment. The midtreatment image was rigidly aligned with the baseline scan in two ways: (1) bony anatomy and (2) carina. Treatment parameters (beam apertures, weights, angles, monitor units, etc.) were transferred to each image. Then, dose was recalculated. Typical IMRT dose constraints were evaluated on all images, and the changes from baseline to each midtreatment image were investigated. Atelectatic lobes experienced mean (stdev) mass changes of -2.8% (36.6%), -24.4% (33.0%), and -9.2% (17.5%) and density changes of -66.0% (6.4%), -25.6% (13.6%), and -17.0% (21.1%) for full, partial, and no resolution, respectively. Means (stdev) of dose changes to spinal cord D , esophagus D , and lungs D were 0.67 (2.99), 0.99 (2.69), and 0.50 Gy (2.05 Gy), respectively, for bone alignment and 0.14 (1.80), 0.77 (2.95), and 0.06 Gy (1.71 Gy) for carina alignment. Dose increases with bone alignment up to 10.93, 7.92, and 5.69 Gy were found for maximum spinal cord, mean esophagus, and mean lung doses, respectively, with carina alignment yielding similar values. 44% and 22% of patients had at least one metric change by at least 5 Gy (dose metrics) or 5% (volume metrics) for bone and carina alignments, respectively. Investigation of GTV coverage showed mean (stdev) changes in V , D , and D of -5.5% (13.5%), 2.5% (4.2%), and 0.8% (8.9%), respectively, for bone alignment with similar results for carina alignment. Resolution of atelectasis caused mass and density decreases, on average, and introduced substantial changes in normal tissue dose metrics in a subset of the patient cohort.
Carcinoma, Non-Small-Cell Lung - complications Carcinoma, Non-Small-Cell Lung - diagnostic imaging Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Humans Lung Neoplasms - complications Lung Neoplasms - diagnostic imaging Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Organs at Risk - radiation effects Pulmonary Atelectasis - complications Radiation Dosage Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted Tomography, Spiral Computed Tumor Burden - radiation effects

Details

Metrics

Logo image